Synthesis and Characterization of Iodinated Tetrahydroquinolines Targeting the G Protein-Coupled Estrogen Receptor GPR30
- 30 December 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (3) , 1004-1014
Abstract
A series of iodo-substituted tetrahydro-3H-cyclopenta[c]quinolines was synthesized as potential targeted imaging agents for the G protein-coupled estrogen receptor GPR30. The affinity and specificity of binding to GPR30 versus the classical estrogen receptors ERα/β and functional responses associated with ligand-binding were determined. Selected iodo-substituted tetrahydro-3H-cyclopenta[c]quinolines exhibited IC50 values lower than 20 nM in competitive binding studies with GPR30-expressing human endometrial cancer cells. These compounds functioned as antagonists of GPR30 and blocked estrogen-induced PI3K activation and calcium mobilization. The tributylstannyl precursors of selected compounds were radiolabeled with 125I using the iodogen method. In vivo biodistribution studies in female ovariectomized athymic (NCr) nu/nu mice bearing GPR30-expressing human endometrial tumors revealed GPR30-mediated uptake of the radiotracer ligands in tumor, adrenal, and reproductive organs. Biodistribution and quantitative SPECT/CT studies revealed structurally related differences in the pharmacokinetic profiles, target tissue uptake, and metabolism of the radiolabeled compounds as well as differences in susceptibility to deiodination. The high lipophilicity of the compounds adversely affects the in vivo biodistribution and clearance of these radioligands and suggests that further optimization of this parameter may lead to improved targeting characteristics.Keywords
This publication has 46 references indexed in Scilit:
- In vivo effects of a GPR30 antagonistNature Chemical Biology, 2009
- Expression of estrogen receptor GPR30 in the rat spinal cord and in autonomic and sensory gangliaJournal of Neuroscience Research, 2009
- Nuclear and Extranuclear Pathway Inputs in the Regulation of Global Gene Expression by Estrogen ReceptorsMolecular Endocrinology, 2008
- The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC‐12 cellsJournal of Neurochemistry, 2008
- Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial CancersJournal of Nuclear Medicine, 2008
- Epidermal Growth Factor Induces G Protein-Coupled Receptor 30 Expression in Estrogen Receptor-Negative Breast Cancer CellsEndocrinology, 2008
- The G Protein-Coupled Receptor GPR30 Inhibits Human Urothelial Cell ProliferationEndocrinology, 2008
- Estrogen Signaling Characteristics of Atlantic Croaker G Protein-Coupled Receptor 30 (GPR30) and Evidence It Is Involved in Maintenance of Oocyte Meiotic ArrestEndocrinology, 2008
- GPR30 Contributes to Estrogen-Induced Thymic AtrophyMolecular Endocrinology, 2008
- Linkage Effects on Binding Affinity and Activation of GPR30 and Estrogen Receptors ERα/β with Tridentate Pyridin-2-yl Hydrazine Tricarbonyl−Re/99mTc(I) ChelatesJournal of the American Chemical Society, 2006